To provide an experimental basis for a comprehensive molecular modeling evaluation study, 500 fragments from the Maybridge fragment library were soaked into crystals of bovine pancreatic trypsin and the structures determined by X-ray crystallography. The soaking experiments were performed in both single and pooled aliquots to determine if combination of fragments is an appropriate strategy. A further set of data was obtained from co-crystallizing the pooled fragments with the protein. X-ray diffraction data were collected on approximately 1000 crystals at the Australian Synchrotron, and these data were subsequently processed, and the preliminary analysis was performed with a custom software application (Jigsaw), which combines available software packages for structure solution and analysis. (Journal of Biomolecular
INTRODUCTION
T he in silico modeling community lacks a public set of high-quality data against which predictive rather than retrospective studies can be performed. Previous attempts to perform such evaluations suffered from a lack of truly "blind" data. 1 Recently, OpenEye Scientific Software has initiated the SAMPL (Statistical Assessment of the Modeling of Proteins and Ligands) meeting, which provides a forum for the prospective testing of concepts, algorithms, and approaches from computational chemistry and protein modeling (http://sampl.eyesopen.com). One core goal of modeling is rapid and reliable in silico screening, in which a compound library is evaluated against a protein target of interest to select a subset of compounds, enriched for potential activity against the target. The resulting subset can subsequently be assayed for activity by using biochemical or biophysical methods. Recently, it has been shown that this approach may be feasible for enriching fragment libraries of low molecular weight (~200 Da) in addition to libraries of larger "lead-like" compounds (300-500 Da). 2 Direct comparison of in silico screening studies to experimental methods is challenging, as the extensive compound collections found in large pharmaceutical companies (10 6 or more compounds) are typically screened in high-throughput assays, which are often indirect measures of compound binding to the target of interest. An exhaustive biophysical assay would be prohibitive in both time and resources. Retrospective studies, where compounds from rounds of medicinal chemistry optimization are "hidden" in the general collection of decoy molecules and then retrieved using computation, do not provide a realistic measure of performance. These studies often assume that all decoy molecules are inactive, and the known molecules reflect the activity of typical screening hits. Typically, the known ligands are highly optimized toward the target and do not reflect the typical low micromolar leads found in an experimental screen.
The SAMPL organizers have proposed a modeling challenge that is close enough to problems encountered by the modeling community in "real life" to be relevant yet limited enough to allow the creation of an extensive experimentally derived data set for comparison. In this challenge (SAMPL2), a protease enzyme (trypsin) is the target, and the challenge is to predict not only which members of a limited compound library (the Maybridge fragment library) bind to this target but also the binding geometry and modes of interaction. Trypsin was chosen as the target for SAMPL2 as it is available commercially, crystallizes readily, diffracts well, and is a member of a known target family-which includes thrombin, factor X, and other serine proteases of pharmaceutical relevance. 3 The Maybridge fragment library has been used by a number of groups for fragment screening and is commercially available. The Maybridge fragment library contains heterocycles without reactive functionalities (such as sulfonyl chlorides) that generally obey the "rule of 3" and are aqueous soluble. 4 The experimental data set that will be used as a baseline for comparing the modeling predictions has been named "the DINGO data set."
In this article, we present the methods that were used to produce the crystal structures that comprise much of the DINGO data set for this SAMPL2 challenge.
METHODS AND MATERIALS

Creation of a master deep-well block of pooled fragments
The Maybridge fragment library (500 compounds, ~30 mg of each; http://www.maybridge.com) was purchased in 2006. An initial set of compounds was brought up in 0.5 mL acetonitrile, but many were insoluble in this solvent. These were put into a 96-deep-well block and dried down in a Genevac centrifuge/ dryer (Genevac, NY). All of the compounds, including those initially brought up in acetonitrile, had 0.5 mL DMSO added to solubilize them. Each of these was transferred to a single well of six 96-deep-well storage plates, which were labeled "master block I-VI" (the sixth block contained only 20 compounds). Each compound was positioned within the 6 master blocks such that using a robot or multichannel pipette, one could transfer compounds from the 6 master blocks into a single "pooled plate," such that within any pool, the compounds were sufficiently different in size and structure to be distinguished crystallographically. Each pooled plate well thus contained fragments from each of the equivalent wells in the 6 master plates. Twenty wells (wells A1-B8) of the pooled plate contained 6 fragments, and the other 76 wells of the pooled plate contained 5 fragments. Fifteen of the compounds were insoluble in 100% DMSO, and another 46 were only partially soluble at the master block concentration (200-400 mM compound). The concentration of the pooled fragments was 30 to 80 mM, depending on the solubility of the fragment and whether there were 5 or 6 fragments in the set. The final concentrations used for soaking were in the 1-to 10-mM range.
Crystal soaking
Crystals of bovine pancreatic trypsin have been reported in the literature since at least 1931, 5 under a number of different conditions. 6 Trypsin is most commonly crystallized in the presence of an inhibitor, often benzamidine hydrochloride, which is a 35-micromolar inhibitor of the enzyme. 7 We screened a ternary complex of 50 mg/mL bovine pancreatic trypsin (Sigma T1426) with 10 mM benzamidine hydrochloride (Sigma B6506) and 10 mM calcium chloride (Fluka 21098) against a number of commercial sparse matrix screens (the JCSG+ and PACT Suites from Qiagen [Venlo, The Netherlands], SaltRx from Hampton Research [Aliso Viejo, CA]) and two 96-well in-house screens (a systematic grid of ammonium sulfate against different buffers and a random combination of chemicals that has been reported for "open"-form trypsin crystals 8 ). The experimental droplets were composed of 200 nL protein solution and 200 nL crystallant solution equilibrated against 50 µL of the crystallant solution in Innovadyne SD2 sitting drop plates (Innovadyne, Santa Rosa, CA). Large crystals suitable for X-ray diffraction appeared in well H7 of the JCSG+ Suite (200 mM ammonium sulfate, 100 mM Bis-Tris [pH 5.5], 25% [w/v] PEG 3350, measured pH 5.57). These crystals were cryo-protected by rapid immersion in a cryo-protection solution containing the reservoir solution supplemented with 15% ethylene glycol and, when cryo-cooled "in the stream," diffracted to better than 1.2 Å at beamline PX1 of the Australian Synchrotron.
Soaks were performed by making up the ethylene glycolcontaining cryo-protection solution at 105% (i.e., leaving out 5% of the water) and replacing the water with an equivalent volume of a (pooled) fragment dissolved in DMSO, yielding a "cryo/fragment solution." The cryo/fragment solution (1 µl) was added to the crystallization droplet, and after 24 h, the crystal was moved into a fresh 1-µL droplet of the cryo/fragment solution.
After analyzing around 50 of the pooled fragments soaked in this way, it became apparent that the fragments were not displacing the bound benzamidine (required for crystallization) during the soaking process. We then tested the ability of more weakly binding inhibitors to support crystallization. After some crystallization trials with benzylamine (0.3 mM inhibition), 4-methylbenzylamine (1.5 mM inhibition), 4-chlorobenzylamine (0.7 mM inhibition), 4-methoxybenzylamine (1 mM inhibition), and 4-aminomethylbenzoic acid (2 mM inhibition), we determined that only benzylamine (Aldrich 185701) gave reproducible crystal formation, and this complex also grew in the JCSG+ suite condition H7, although the crystals were visually less perfect than the benzamidine-inhibited enzyme. Additive screens (Additive Screen, Hampton Research; The Optisalt Suite, Qiagen) indicated that better benzylamine/trypsin crystals grew with the addition of 0.12 M sodium thiocyanate and 10 mM Tris (pH 8.5).
Large-scale production of crystals for soaking experiments was carried out by setting up a crystal droplet in only the top subwells of the SD2 sitting drop plates, with the droplets consisting of 300 nL protein solution (2 mM [47 mg/mL] trypsin, 4 mM benzylamine, and 10 mM calcium chloride), 195 nL of the production reservoir solution (22.5% PEG 3350, 0.18 M ammonium sulfate, 0.12 M sodium thiocyanate, 0.09 M Bis-Tris [pH 5.5], 0.01 M Tris [pH 8.5], measured pH 5.82), and 5 nL of a seed stock, made by crushing a crystal into the reservoir solution using a Teflon sphere 9 and diluting to a suitable concentration. The crystallizations were set up with a "Phoenito" protocol, 10 where a Phoenix robot (Art Robbins Instruments, Sunnyside, CA) was used to dispense the protein into an SD2 crystallization plate (prefilled with 50 µL reservoir solution), and a Mosquito robot (TTP Labtech, Melbourn, UK) was used to dispense the reservoir solution and seed stock over the protein droplet. Plates were incubated in a Gallery 700 incubator and imaged on a Minstrel HT imager (Rigaku Automation, Carlsbad, CA).
To minimize the amount of human handling involved in soaking the crystals, the Mosquito robot was used to dispense the cryo/fragment solution onto the crystal-containing droplets and also to dispense another 1-µL droplet of the same solution into the unused second subwell of the SD-2 plate. The protocol is set up so the addition to the crystal droplets completes first, decreasing the chance of the crystal droplets drying out during the transfer of the second droplet to the empty subwells of the plate. The cryo/fragment cocktails are prepared and stored in 96-well V-bottomed microplates.
After 1 or more days, the crystals were transferred from their original growth droplet into the benzylamine-free second droplet for further equilibration. After no less than 12 h in this second droplet, the crystals were harvested into polyimide (Mylar) loops (MiTeGen, Ithaca, NY), plunge-cooled into liquid nitrogen, and stored in 96-port cassettes (Crystal Positioning Systems, Girard, PA) for data collection.
Co-crystallization
Tests were run concurrently to use fragment binding as a precondition for crystallization. Because an inhibitor such as benzylamine is required for crystal growth, it was hypothesized that fragments that bound trypsin would allow for crystal growth in the absence of inhibitor. Initial tests showed that seeded droplets containing 300 nL of inhibitor-free protein solution (2 mM trypsin, 10 mM calcium chloride) and 200 nL of the production crystallant did not yield crystals. Test protein/inhibitor solutions, in which 19 µL of 2 mM trypsin/10 mM CaCl 2 was premixed with 1 µl 4 mM benzylamine or benzamidine, produced crystals when set up in droplets containing 300 nL protein/ inhibitor, 195 nL production reservoir solution, and 5 nL seed stock. Then, 96 protein/fragment solutions were prepared in a 96-well V-bottomed microplate, where each well contained 19 µL of the 2 mM trypsin/10 mM CaCl 2 solution and 1 µl of the pooled fragments from the master block.
The co-crystallizations were set up using a "Phoenito" protocol in which 12 × 300-nL and 12 × 200-nL droplets of each protein/fragment were dispensed into the top and bottom subwells, respectively, of a row of an SD2 plate. This was followed by the addition of 195 nL production reservoir + 5 nL seed stock or 295 nL production reservoir + 5 nL seed stock to yield 24 drops of 500 nL total volume, 12 at a 60:40 ratio of protein/fragment:reservoir ratio and 12 at a 40:60 protein/ fragment:reservoir ratio. Twelve 96-well crystallization plates were set up for 1 set of 96 cryo/fragment solutions, where each plate contained only 1 column of 8 fragments from the master block. This gives 12-fold redundancy for each pooled fragment set at 2 different protein:reservoir ratios.
This co-crystallization experiment was repeated, using a protein solution that contained only 2 mM trypsin (no added CaCl 2 ).
X-ray data collection
In total, 181 frames of 1° oscillations were collected on each crystal at beamline PX1 of the Australian Synchrotron. The wavelength for the experiments was 0.98 Å, and data routinely extended beyond 1.4 Å.
Data processing and interpretation
The images gathered at the Australian Synchrotron were analyzed using a locally written Python (Version 2.4.2 11 ) script called Jigsaw. The process is divided into stages. Each stage has a BASH shell script, which executes mostly public domain software. The Table shows each stage and the software used.
The scripts must be given all the parameters (e.g., cell dimensions, space group) and the path to a set of directories containing the images before analysis can start. Jigsaw will detect all valid image sets and analyze them without pausing to wait for user entry. The Jigsaw scripts process the raw X-ray diffraction data, find and refine the position of the trypsin protein molecule using the data, and attempt to fit the appropriate small molecule into any appropriate unfilled electron density.
First, in the index stage, XDS 12 was used to index the raw data images where the known unit cell dimensions of bovine trypsin were input. The wavelength, crystal-to-detector distance, and oscillation range per image are automatically harvested from the image header. The refined matrix from XDS indexing was used to carry out integration using XDS. The separation of indexing and integration (which are usually sequential in XDS) allowed for early triage of poor data sets. The Jigsaw script allows determination of the failed processing stage, if the data fail to be successfully processed. By separating the various steps, it was possible to distinguish those data sets with different space groups (or other problems) and work on these in manual mode.
After integration by XDS, the program POINTLESS was used to convert the output hkl file into a format suitable for input to SCALA. Scaling was carried out using SCALA, and the intensities were converted to structure factors using TRUNCATE.
A master Rfree set was used in all data processing and was added to all data using UNIQUE, FREERFLAG, CAD, and MTZUTILS. Molecular replacement was carried out using a template trypsin model (PDB code 2BLV) and PHASER. The output model from PHASER was refined using REFMAC5 to the resolution limit of the scaled data. Programs POINTLESS through to REFMAC5 are part of the Collaborative Computing Project 4 (CCP4 13 ).
The dock stage uses an Excel (http://office.microsoft .com/excel) spreadsheet containing the SMILES 14 strings for the ligands and the corresponding subdirectory name of the image set. Excel was used as this was the format the fragment information arrived in from Maybridge. The script reads the spreadsheet and converts the SMILES string into a coordinate file using xlhtml (http://chicago.sourceforge.net/xlhtml), omega2, and writedict (both from OpenEye Scientific Software, Santa Fe, NM).
Ligands were found using the FINDLIGAND module in COOT 15 and by using the Flynn program (OpenEye Scientific Software).
Combined overlap scores are calculated using tanny2 and taffeetee to obtain Tanimotos 16 and sfall, mapmask and overlapmap from the CCP4 suite. Tanny2 and taffetee are written in C++ and use the CLIPPER library 15 to read and process the ligand and electron density files.
RESULTS AND DISCUSSION
The benzylamine-inhibited trypsin crystals required seeding to reliably produce crystals, and the concentration of the seed stock had to be carefully adjusted to introduce only a small number of stable nuclei into the nascent crystallization droplets.
Too concentrated a seed stock solution yields droplets with large numbers of intergrown, smaller crystals (Fig. 1a) , and a diluted stock does not yield crystals. The ideal case in which only one stable nucleus is introduced into the droplet (Fig. 1b) is unfortunately very close to the suboptimal case where no nuclei are introduced. Even where the seed stock concentration is appropriate, the crystals produced were not always of data quality (Fig. 1c) . Figure 2 shows the rate of crystal production for the first 13 production crystallization plates. During the course of producing the crystals for SAMPL, no crystallization plate was ever produced where there were diffraction quality crystals in all of the 96 droplets. This complicated the soaking process: instead of using the Mosquito robot to do a 1-to-1 transfer from the v-plate containing 96 cryo/fragment solutions onto the crystallization plates, we had to do duplicate soaking experiments. Analysis of the spread of crystals in the first 13 production crystallization plates suggested that we would require at least 5-fold replication of the automated 1-to-1 soaking to get complete coverage. The Mosquito robot works by spooling out 8 disposable tips and aspirating/dispensing in a column-wise fashion. We examined the crystallization plates by eye and determined which columns could be combined to give a combined column set with a least 1 "harvestable" crystal in each row. Then we added the same cryo/fragment solution to each column in the column set. By bunching columns together in this way, we could obtain essentially complete coverage for soaking using 30 columns of production crystals or fewer than 3 crystallization plates.
Crystals were observed (in some replicate drops) in most of the initial co-crystallization experiments, in which a mixture of trypsin/CaCl 2 /pooled fragments was used as the protein component of the crystallization experiment. The high redundancy of the experiment was justified, as very few of the pooled fragments showed crystals in each of the 24 droplets; there were a greater number of the 60:40 ratio drops that yielded crystals, but bigger crystals were generally seen in the 40:60 ratio droplets. Many of the droplets showed a mass of tiny crystals, and many of the crystals also showed no obvious density for any fragment. Trypsin is known to be stabilized by calcium, 17 and the metal arguably provides enough stabilization to allow for crystallization at the high concentrations of protein used in the experiment even without the any additional inhibition through fragment binding. The co-crystallization experiments produced far fewer crystals when repeated using a protein/pooled fragment solution without added calcium chloride. Both co-crystallizations with and without added calcium chloride produced crystals in a number of different space groups, despite being seeded with the standard P2 1 2 1 2 1 crystals.
A test soak was performed by adding 1 µl of cryo/benzamidine (95 µL 105% cryo, 5 µL 200 mM benzamidine in DMSO) solution mixture to a droplet containing a crystal of the benzylamine/CaCl 2 /trypsin complex. After 24 h, the crystal was transferred to a fresh droplet of cryo/benzamidine and left overnight. In-house X-ray data were collected on this crystal and showed that the benzamidine had displaced the benzylamine (Fig. 3) .
The results viewed in Jigsaw show the list of data sets and progress reports (Pass/Fail). The highest Tanimoto score is displayed to the right of the Pass/Fail score, and the data sets are ordered from highest to lowest Tanimoto. Tanimoto scores higher than 0.3 generally suggest that a ligand at least partially fits into the electron density seen in the data. For those that receive a Pass score, the resulting structure and electron density can be viewed in a separate graphics window running COOT.
Of the 270 trypsin data sets analyzed so far, 90% of the structures were successfully solved without modification of the input parameters. "Success" in this case means that the data led to machine or human interpretable electron density maps, and a model of the protein, waters, ligands, and so on could be refined. Of the 10% that failed, 32% contained crystals that were formed via co-crystallization. Many of the co-crystallization data sets have been solved subsequently by modification of the space group and cell dimension parameters.
This article describes the techniques and protocols that were used to produce the X-ray structures in the DINGO trypsin/ fragment data set for the second SAMPL challenge. Although fragment screening has become a more popular method in the drug discovery process, few groups have attempted to in silico screen fragments into targets of interest. 2 It is a more challenging problem than screening larger molecules as there are fewer interactions possible, and the binding energies are quite small. The SAMPL challenge is set up to provide a forum to test new modeling methodologies for their predictive power.
The production of trypsin crystals required the inclusion of an inhibitor in the crystallization sample, so the fragment soaking experiments were competition experiments rather than simple binding studies. We believe that the limitations inherent in a competition binding experiment-that the soaked fragments would have to bind more strongly to the active site than the crystallization ligand-are mitigated by the 2-step soaking protocol, where the preformed crystals had fragments added to the growth droplet, followed by transfer of the crystal with minimal drop liquid into a second droplet containing fragment but no crystallization ligand. This is borne out in the results, where we see empty active sites when the fragment is not bound. Where we do see fragments, there is clear density with a limited number of orientations for the fragment.
Many biophysical techniques are used routinely to identify binding of fragments (or other molecules) to target proteins. 18 Although this article focuses on crystallography, other techniques (e.g., surface plasmon resonance) will be included in the experimental DINGO data set provided for the SAMPL2 challenge. Although not completely comprehensive, the data collected for this project should be comprehensive enough to provide a benchmark for the modeling community to test against.
